Keith Van Haren, MD

Assistant Professor of Neurology (Pediatric Neurology) and of Pediatrics

Clinical Focus

Autoimmune Diseases of the Nervous System
Adrenoleukodystrophy
Multiple Sclerosis
Autoimmune encephalitis
MOGAD
Leukodystrophies
Neurology with Special Qualifications in Child Neurology

Academic Appointments

Assistant Professor - University Medical Line, Neurology
Assistant Professor - University Medical Line, Pediatrics
Member, Maternal & Child Health Research Institute (MCHRI)
Member, Wu Tsai Neurosciences Institute

Honors & Awards

Excellence in Clinical Neurology, Stanford Dept of Neurology (2021)
Ann Moser Award for Science & Humanism, ALD Connect (2020)
Finalist, DP2 New Innovator Award, NIH (2019)
Morgridge Endowed Faculty Scholar in Pediatric Translational Medicine, Stanford Maternal & Child Health Research Institute (2019)
K23 Clinician-Scientist Training Award, NIH/NINDS (2015)
PERF-CNF Scientific Award, Child Neurology Foundation (2011)
Chief Resident, Stanford Dept Neurology (2009)
Medical Student Teaching Award, Stanford Dept Neurology (2009)
Commencement Speaker, University of Rochester School of Medicine (2005)
Inductee, Arnold Gold Humanism Honor Society (2004)
Moore Award, Honorable Mention, American Association of Neuropathology (2003)

Boards, Advisory Committees, Professional Organizations

Founding Member, ALD Connect (2014 - Present)
Founding Member, The Global Leukodystrophy Initiative (GLIA) (2014 - Present)

Professional Education

Board Certification: American Board of Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology (2010)
BA, College of the Holy Cross, Chemistry (1999)
MD, University of Rochester School of Medicine, Medicine (2005)
PGY1-2 Pediatrics, Massachusetts General Hospital, Pediatrics (2007)
PGY3-5 Neurology, Stanford University Hospitals & Clinics, Child & Adult Neurology (2010)
Fellowship, Stanford University Hospital & Clinics, Neuroimmunology (2012)
Post-doc, Steinman & Robinson Labs, Stanford University, Neuroimmunology (2014)

Contact

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

Child Neurology 730 Welch Rd Ste 206 Palo Alto CA 94304 Tel: (650) 723-0993 Fax: (650) 721-6350

Additional Clinical Info

Stanford Medicine Children's Health

Current Research and Scholarly Interests

Our research group is dedicated to developing novel interventions for children at risk for neurodegenerative disorders. We are focused primarily on multiple sclerosis and X-linked adrenoleukodystrophy, both of which involve inflammatory and metabolic disruption to brain myelin. In addition to rescue therapies, we are interested in the role of nutrient deficiencies in disease mechanism and prevention.

Clinical Trials

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy Recruiting
More
A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adults Male Subjects with Cerebral Adrenoleukodystrophy.
Lead Sponsor
Stanford Investigators
- Keith Van Haren, MD
View full details
The Myelin Disorders Biorepository Project Recruiting
More
The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects. The MDBP is one of the world's largest leukodystrophy biorepositories, having enrolled nearly 2,000 affected individuals since it was launched over a decade ago. Researchers working in the biorepository hope to use these materials to uncover new genetic etiologies for various leukodystrophies, develop biomarkers for use in future clinical trials, and better understand the natural history of these disorders. The knowledge gained from these efforts may help improve the diagnostic tools and treatment options available to patients in the future.
Lead Sponsor
Stanford Investigators
- Keith Van Haren, MD
View full details
A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel Recruiting
More
The main aim of this study is to assess and describe the safety outcomes, including newly diagnosed malignancies, of patients with CALD treated with eli-cel in the post-marketing setting (tradename Skysona) and to describe major functional disability (MFD)-free survival over time in participants with more advanced early active CALD. All enrolled participants with CALD treated with eli-cel in the post-marketing setting will be followed in this study for 15 years. No investigational drug product will be administered in this study. This study will enroll 120 participants with CALD treated with eli-cel in the post-marketing setting. A subpopulation of 24 participants with more advanced early active CALD will be specifically enrolled as required by the US FDA as a condition of accelerated approval and will be considered as a separate cohort for effectiveness outcomes.
Lead Sponsor
Stanford Investigators
- Keith Van Haren, MD
View full details
A Study to Evaluate the Safety and Efficacy of ION373 in Patients With Alexander Disease (AxD) Recruiting
More
The purpose of this study is to evaluate the safety and efficacy of zilganersen (ION373) in improving or stabilizing gross motor function across the full range of affected domains in patients with AxD.
Lead Sponsor
Stanford Investigators
- Keith Van Haren, MD
- maura ruzhnikov
View full details
A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy Not Recruiting
More
In this pilot study, the investigators will assess the safety of two high-dose regimens of oral vitamin D supplementation and measure the effects of vitamin D supplementation on markers of oxidative stress and inflammation in the blood and brain of study participants before, during, and after taking vitamin D supplements. The goal of the study is to establish research measures (i.e. biomarkers) and an optimal dose for vitamin D supplementation in boys with the X-linked adrenoleukodystrophy (ALD) genotype.

Stanford is currently not accepting patients for this trial. For more information, please contact Keith Van Haren, MD, .

Lead Sponsor
- Stanford University
Stanford Investigators
- Keith Van Haren, MD
View full details

2023-24 Courses

Independent Studies
- Medical Scholars Research
  MED 370 (Aut, Win, Sum)
- Undergraduate Research
  NENS 199 (Aut, Win, Spr)

Stanford Advisees

Postdoctoral Faculty Sponsor
Danielle Kim

All Publications

Profiles With Related Publications

close
Patrick Barnes

Professor of Radiology (Pediatric Radiology) at the Stanford University Medical Center, Emeritus
Research Interests
Advanced imaging, including magnetic resonance imaging, of injury to the developing central nervous system; including fetal, neonatal, infant and young child; and, including nonaccidental injury (e.g. child abuse).

See Biosketch for details.

193 Total Publications
close
Alice Bertaina MD, PhD

Lorry I. Lokey Professor
Clinical Focus
Pediatric Stem Cell Transplantation, Graft engineering, Pediatric Hematology-Oncology

194 Total Publications
close
Marion S. Buckwalter, MD, PhD

Professor of Neurology (Adult Neurology) and of Neurosurgery
Clinical Focus
Neurologic Critical Care, Neurocritical Care
Research Interests
The goal of the Buckwalter Lab is to improve how people recover after a stroke. We use basic and clinical research to understand the cells, proteins, and genes that lead to successful recovery of function, and also how complications develop that impact quality of life after stroke. Ongoing projects are focused on understanding how inflammatory responses are regulated after a stroke and how they affect short-term brain injury and long term outcomes like dementia and depression.

99 Total Publications
close
Katie Cederberg

Postdoctoral Scholar, Psychiatry

53 Total Publications
close
Gary Dahl

Professor of Pediatrics (Hematology/Oncology), Emeritus
Research Interests
Hematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.

171 Total Publications
close
John W. Day, MD, PhD

Professor of Neurology (Adult Neurology), of Pediatrics (Genetics) and, by courtesy, of Pathology
Clinical Focus
Neuromuscular Medicine
Research Interests
Our Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.

388 Total Publications
close
Paul Graham Fisher, MD

Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
Clinical Focus
Cancer > Neuro Oncology, Neurology - Child Neurology, Neuro-Oncology, Neurology
Research Interests
Clinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors and other cancers in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies.

276 Total Publications
close
Kristin Galetta, MD

Clinical Assistant Professor, Neurology & Neurological Sciences
Clinical Focus
Neurology

31 Total Publications
close
Jin S. Hahn, MD

Professor of Neurology at the Stanford University Medical Center, Emeritus
Research Interests
1. Clinical informatics and electronic health records
2. Neonatal and fetal neurology
3. Prenatal diagnosis neurodevelopmental anomalies
4. Personalized Health and Wellness Records

80 Total Publications
close
May Han, MD

Associate Professor of Neurology (Adult Neurology)
Clinical Focus
Neuroimmunology, Multiple sclerosis (MS), Neuromyelitis optica, High risk MS, MS pregnancy, Clinical Neurophysiology

86 Total Publications
close
Melanie Hayden Gephart

Professor of Neurosurgery and, by courtesy, of Neurology
Clinical Focus
Neurosurgery

155 Total Publications
close
Yang Hu, MD, PhD

Associate Professor of Ophthalmology
Research Interests
The ultimate goal of the laboratory is to develop efficient therapeutic strategies to achieve CNS neural repair, through promoting neuroprotection, axon regeneration and functional recovery.

More specifically, we study retinal ganglion cell (RGC) and optic nerve in various optic neuropathies including traumatic, glaucomatous and inflammatory optic nerve injuries to fully understand the molecular mechanisms of CNS neurodegeneration and axon regeneration failure.

60 Total Publications